Biofrontera Inc. (BFRI)

Profile

https://www.biofrontera-us.com

Biofrontera Inc. is a U.S.-based biopharmaceutical company focused on dermatology products with an emphasis on photodynamic therapy. Its commercial portfolio centers on Ameluz, a prescription topical gel used together with BF-RhodoLED and RhodoLED lamp systems for the treatment of actinic keratoses, a common precancerous skin condition. The company also markets Xepi, a topical antibiotic for impetigo, expanding its presence in prescription skin care. Biofrontera works directly with dermatology practices and specialist groups, supporting clinical use through products designed for office-based treatment settings. Headquartered in Woburn, Massachusetts, Biofrontera plays a niche role in the dermatology market by combining drug and device-based therapies for targeted skin treatment.